Insmed Dividend

Dividend criteria checks 0/6

Insmed does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield2.9%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-US$5.05
Dividend yield forecast in 3Y0%

Recent dividend updates

No updates

Recent updates

Insmed Incorporated (NASDAQ:INSM) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Feb 25
Insmed Incorporated (NASDAQ:INSM) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Insmed Incorporated (NASDAQ:INSM) Investors Are Less Pessimistic Than Expected

Dec 18
Insmed Incorporated (NASDAQ:INSM) Investors Are Less Pessimistic Than Expected

Getting In Cheap On Insmed Incorporated (NASDAQ:INSM) Is Unlikely

Jul 28
Getting In Cheap On Insmed Incorporated (NASDAQ:INSM) Is Unlikely

Calculating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)

Jul 01
Calculating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)

Would Insmed (NASDAQ:INSM) Be Better Off With Less Debt?

Apr 18
Would Insmed (NASDAQ:INSM) Be Better Off With Less Debt?

A Look At The Fair Value Of Insmed Incorporated (NASDAQ:INSM)

Feb 23
A Look At The Fair Value Of Insmed Incorporated (NASDAQ:INSM)

Insmed inks financing agreements to raise $500M

Oct 19

Does Insmed (NASDAQ:INSM) Have A Healthy Balance Sheet?

Oct 17
Does Insmed (NASDAQ:INSM) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Insmed Incorporated (NASDAQ:INSM) Suggests It's 46% Undervalued

Sep 20
An Intrinsic Calculation For Insmed Incorporated (NASDAQ:INSM) Suggests It's 46% Undervalued

Insmed rises 16% on better-than-expected Q2 result

Aug 04

Is Insmed (NASDAQ:INSM) A Risky Investment?

Jun 24
Is Insmed (NASDAQ:INSM) A Risky Investment?

Insmed: Temporarily Stuck

Feb 19

Is Insmed (NASDAQ:INSM) Using Debt Sensibly?

Dec 11
Is Insmed (NASDAQ:INSM) Using Debt Sensibly?

Is Insmed (NASDAQ:INSM) Using Too Much Debt?

Sep 10
Is Insmed (NASDAQ:INSM) Using Too Much Debt?

Estimating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)

Jun 10
Estimating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)

Insmed to raise $250M in stock offering, $500M in notes offering

May 10

We Think The Compensation For Insmed Incorporated's (NASDAQ:INSM) CEO Looks About Right

May 06
We Think The Compensation For Insmed Incorporated's (NASDAQ:INSM) CEO Looks About Right

Is Insmed (NASDAQ:INSM) Weighed On By Its Debt Load?

Apr 06
Is Insmed (NASDAQ:INSM) Weighed On By Its Debt Load?

Have Insiders Been Selling Insmed Incorporated (NASDAQ:INSM) Shares?

Mar 02
Have Insiders Been Selling Insmed Incorporated (NASDAQ:INSM) Shares?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if INSM's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if INSM's dividend payments have been increasing.


Dividend Yield vs Market

Insmed Dividend Yield vs Market
How does INSM dividend yield compare to the market?
SegmentDividend Yield
Company (INSM)n/a
Market Bottom 25% (US)1.5%
Market Top 25% (US)4.7%
Industry Average (Biotechs)2.9%
Analyst forecast in 3 Years (INSM)0%

Notable Dividend: Unable to evaluate INSM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate INSM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate INSM's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as INSM has not reported any payouts.


Discover strong dividend paying companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.